WANT A PROFILE LIKE THIS?
Gopal N Gupta
Summary
"Dr. Gupta received his B.S. (Biological Chemistry) from the University of Chicago in 1996. He received his M.D. from the University of Illinois at Chicago in 2002. He then performed his residency in urologic surgery at the University of Maryland Medical Center (2002-2008). He continued his training as a fellow in Urologic Oncology at the National Cancer Institute (NIH) in the Urologic Oncology Branch under the guidance of Dr. W. Marston Linehan (2008-2011). In 2011 he was recruited to the Department of Urology by Dr. Robert Flanigan as a fellowship trained urologic oncologist. Dr. Gupta holds a primary appointment in the Department of Urology, and has a joint appointment in the Department of Surgery, Radiology and the Oncology Institute at the Cardinal Bernardin Cancer Center.
His primary clinical research interests pertain to bladder, kidney and prostate cancer. Dr. Gupta performs minimally invasive surgeries using the DaVinci Robotic Surgery platform. His clinical interests are to push the cutting edge of technology while optimizing cancer outcomes. He has published extensively about varied topics in gentiourinary oncology including: MRI/TRUS fusion ultrasound guided prostate biopsy, Active Surveillance for prostate cancer, optimizing renal functional outcomes for partial nephrectomy, improving surgical decision making in prostate cancer surgery using MRI, health services related research aimed at addressing disparities in care delivery in genitourinary oncology.
Dr. Gupta’s laboratory is located in the oncology institute. He has been named a Dean’s Office Clinical Scholar and splits his time between his clinical responsibilities and his research interests. His laboratory is active in: 1) creating pre-clinical models in bladder and kidney cancer to assess the effects of emerging targeted therapies, 2) understanding the role of cancer shed exosomes as biomarkers, their role in progression of cancer and EMT, 3) the role of hypoxia signaling in renal and bladder malignancy."
